Talk:Emsam

From Wikipedia, the free encyclopedia

Emsam is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Stub This article has been rated as stub-Class on the quality scale.

[edit] Redirecting this page

WP policy is for drugs to be listed under their INN, which would be l-deprenyl, but people have settled on using the name selegeline instead for some reason.

Either way, that article gives more information about the patch than this page, and is the right place for this page to redirect to. Most of the information in this article is not relevant or even correct, and should be moved to the appropriate other pages.

For instance, the bits about the neurologist discovering the tyramine potentiation should be moved to the MAOI page. The rest of the article is either covered in selegiline, or incorrect.

Please reply here, or to my talk page, ASAP if there is any reason not to replace this article with a redirect to the selegiline article. Zuiram 16:40, 6 February 2007 (UTC)

[edit] Requested move

Both WP:NAME and WP:MOSTM seem to indicate that the article name should not be in all caps, even if the trademarked drug name is. Since the page was moved in apparently good faith at some point in the past I'm treating it as a controversial move, even though I think the case for the new name is unambiguous. Zahnrad (talk) 00:25, 14 May 2008 (UTC)

  • Or rather, we should call it what English does, whatever that may be. (We do therefore cap some acronyms, like NATO, but this coinage isn't one.) Support. Septentrionalis PMAnderson 19:25, 14 May 2008 (UTC)
  • Support per FDA Approves Emsam (Selegiline) as First Drug Patch for Depression and lack of explanation for what E.M.S.A.M. is supposed to stand for explanation that it comes from EMily and SAMuel. Definitely support, then. Chocolatechaos9508 (talk) 06:02, 17 May 2008 (UTC)
  • Support Per the etymology of the name, it has no relation to what the product actually is; it is therefore purely stylistic and falls under the trademark guideline of WP:NAME. Ham Pastrami (talk) 07:19, 18 May 2008 (UTC)